SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.410-6.6%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote ()11/4/1998 9:28:00 AM
From: Paul Lee   of 507
 
These guys are as sharp as a tack--they learned of the suit--duh, i guess they opened their mail, or read the Washington Post.

North American Vaccine Advised That Former President Initiates Litigation Against the Company

COLUMBIA, Md., Nov. 4 /PRNewswire/ -- North American Vaccine (Amex: NVX) announced today the Company has learned that Sharon Mates, Ph.D., a director of the Company and the Company's former president, initiated litigation in United States District Court, District of Maryland (the "Complaint") against the Company, two of its directors and BioChem Pharma Inc., a principal shareholder. The claims against the Company seek principally the following: injunctive relief seeking to prevent the Company from consummating a previously announced agreement-in-principle to raise $25 million through a private placement of 4.5% convertible secured notes; injunctive relief against the Company relating to Dr. Mates' access to Company books and records and to her continued service as a director; declaratory relief regarding her termination of employment and removal as president of the Company; claims alleging abusive discharge and defamation. The Complaint also seeks actual and punitive damages in an unspecified amount.

The Company intends to vigorously contest and defend against these claims in this litigation. The Company believes that these claims are without merit and that the Company has meritorious defenses available to it. Accordingly, in the opinion of management, this lawsuit will not have a material adverse effect on the Company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext